Trusted Press Release Distribution   Plans | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
Imarc Group
www.imarcgroup.com/
Kanika Sharma
sales@imarcgroup.com
8130434268
GB Nagar
Nehru Complex

Bookmark and Share
Oncology Based In-Vivo CRO Market Demand, Growth, Overview, and research Report 2025-2033
IMARC Group provides an analysis of the key trends in each segment of the global oncology based in-vivo CRO market report, along with forecasts at the global, regional and country levels from 2025-2033.


Oncology Based In VivoCRO
BriefingWire.com, 3/13/2025 - Market Overview:

The global oncology-based in-vivo Contract Research Organization (CRO) market has experienced significant growth, reaching a valuation of USD 1.3 billion in 2024. Projections indicate that this market will expand to USD 2.4 billion by 2033, exhibiting a Compound Annual Growth Rate (CAGR) of 6.55% during the forecast period of 2025-2033. This growth is primarily driven by the increasing prevalence of cancer worldwide, substantial investments in research and development (R&D) by governments, and the rising demand for personalized medicine.

Study Assumption Years:

Base Year: 2024

Historical Years: 2019-2024

Forecast Years: 2025-2033

Oncology-Based In-Vivo CRO Market Key Takeaways:

Market Size and Growth: The market was valued at USD 1.3 billion in 2024 and is expected to reach USD 2.4 billion by 2033, with a CAGR of 6.55% from 2025 to 2033.

Regional Dominance: North America leads the market, attributed to the high prevalence of various cancer types and substantial investments in oncology research.

Market Segmentation: The market is segmented by indication (blood cancer, solid tumors, others), model (syngeneic, xenograft, patient-derived xenograft, others), and application (hospitals, rehabilitation centers).

Technological Advancements: Innovations such as telehealth and virtual clinical trials are enhancing patient safety and expanding the reach of oncology research.

Personalized Medicine: The growing emphasis on personalized treatment approaches is catalyzing the demand for specialized in-vivo CRO services.

Government R&D Investments: Increased funding in R&D by governments worldwide is propelling market growth.

Key Players:

Champions Oncology Inc.

Charles River Laboratories International Inc.

Crown Bioscience Inc.

Eurofins Scientific

Evotec SE

ICON Plc

Labcorp Drug Development (Laboratory Corporation of America Holdings)

Living Tumor Laboratory

Taconic Biosciences Inc.

The Jackson Laboratory

WuXi AppTec

Xentech

Request Sample For PDF Report: https://www.imarcgroup.com/oncology-based-in-vivo-cro-market/requestsample

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2026 Proserve Technology, Inc.